DK0507187T3 - Fremgangsmåde til hæmning af pulmonær oxygentoksicitet - Google Patents

Fremgangsmåde til hæmning af pulmonær oxygentoksicitet

Info

Publication number
DK0507187T3
DK0507187T3 DK92105035.7T DK92105035T DK0507187T3 DK 0507187 T3 DK0507187 T3 DK 0507187T3 DK 92105035 T DK92105035 T DK 92105035T DK 0507187 T3 DK0507187 T3 DK 0507187T3
Authority
DK
Denmark
Prior art keywords
oxygen toxicity
inhibiting pulmonary
pulmonary oxygen
inhibiting
toxicity
Prior art date
Application number
DK92105035.7T
Other languages
Danish (da)
English (en)
Inventor
Craig D Wegner
L Gordon Letts
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0507187T3 publication Critical patent/DK0507187T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1777—Integrin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK92105035.7T 1991-04-03 1992-03-24 Fremgangsmåde til hæmning af pulmonær oxygentoksicitet DK0507187T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67987091A 1991-04-03 1991-04-03

Publications (1)

Publication Number Publication Date
DK0507187T3 true DK0507187T3 (da) 1997-04-07

Family

ID=24728710

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92105035.7T DK0507187T3 (da) 1991-04-03 1992-03-24 Fremgangsmåde til hæmning af pulmonær oxygentoksicitet

Country Status (13)

Country Link
US (1) US5310551A (es)
EP (1) EP0507187B1 (es)
JP (1) JP3228548B2 (es)
AT (1) ATE145827T1 (es)
AU (1) AU655459B2 (es)
CA (1) CA2064604C (es)
DE (1) DE69215568T2 (es)
DK (1) DK0507187T3 (es)
ES (1) ES2094837T3 (es)
GR (1) GR3022578T3 (es)
HK (1) HK1003106A1 (es)
NZ (1) NZ242192A (es)
ZA (1) ZA922408B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
GB9115364D0 (en) 1991-07-16 1991-08-28 Wellcome Found Antibody
US5708141A (en) * 1992-05-11 1998-01-13 Corvas International, Inc. Neutrophil inhibitors
US20190290623A1 (en) * 2018-03-26 2019-09-26 The Unites States of America Represented by the Secretary of Navy Use of tiotropium bromide to prevent pulmonary oxygen toxicity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109123A (en) * 1988-06-14 1992-04-28 Dana Farber Cancer Institute Alteration of ability of soluble CD4 fragments to bind HIV
US5147637A (en) * 1988-06-07 1992-09-15 The Rockefeller University Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma
DK0387701T3 (da) * 1989-03-09 1992-12-07 Boehringer Ingelheim Pharma Anvendelse af intercellulære adhæsionsmolekyler samt deres bindende ligander ved behandling af astma

Also Published As

Publication number Publication date
AU1398692A (en) 1992-10-08
AU655459B2 (en) 1994-12-22
EP0507187A1 (en) 1992-10-07
HK1003106A1 (en) 1998-10-09
EP0507187B1 (en) 1996-12-04
CA2064604A1 (en) 1992-10-04
CA2064604C (en) 2007-07-10
JP3228548B2 (ja) 2001-11-12
ZA922408B (en) 1992-12-30
US5310551A (en) 1994-05-10
DE69215568T2 (de) 1997-05-15
JPH05255103A (ja) 1993-10-05
ES2094837T3 (es) 1997-02-01
DE69215568D1 (de) 1997-01-16
GR3022578T3 (en) 1997-05-31
ATE145827T1 (de) 1996-12-15
NZ242192A (en) 1997-06-24

Similar Documents

Publication Publication Date Title
DE69232480D1 (de) Beatmungsgerät zur Erzeugung von kontinuierlichem positiven Atemwegdruck (CPAP)
DE69129800D1 (de) Behandlung von menschlichen retrovirus-infektionen mit 2',3'-dideoxyinosin
DE69525369D1 (de) Kontinuierliches polymerisationverfahren von polyamiden
AR001440A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
DE59510421D1 (de) Substituierte Pyridylpyrazole
DK0606351T3 (da) Apparat til sikring af lungetilstanden
DE69425356D1 (de) Pro-Prodrugs, ihre Herstellung und Anwendung
ATE252885T1 (de) Plan zur verabreichung von h+, k+-atpase inhibitoren
TR199901772T2 (es)
NO20000578D0 (no) Et universalt anvendelig blodplasma
ATE143260T1 (de) Verwendung von (s)-isofluran und (s)-desfluran zur anästhesie sowie entsprechende arzneimittelzubereitungen
DK0507187T3 (da) Fremgangsmåde til hæmning af pulmonær oxygentoksicitet
DK0655454T3 (da) Fremgangsmåde til fremstilling af 2,2-difluorketensilylacetaler og alfa,alfa-difluor-beta-silyloxy-1,3-dioxolan-4-propansyreestere
DK0638068T3 (da) Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
DE69200292D1 (de) Cyanocobaltatesauerstoffaddukte.
DK0476113T3 (da) Lægemiddel til behandling af hyperlipidæmi og/eller atherosklerose
DK0422566T3 (da) Fremgangsmåde til fremstilling af 3-(L-pyroglutamyl)-L-thiazolidin-4-carboxylsyre og derivater deraf
DK0403458T3 (da) Hidtil ukendte polypeptider og anvendelse deraf
KR950700988A (ko) 미생물, 이들의 제조방법 및 이들의 사용(Micro-organisms, preparation method therefor and uses thereof)
DK0727219T3 (da) Medicinsk gasblanding
DK0679156T3 (da) Fremgangsmåde til fremstilling af 10-desacetoxybaccatin III og 10-desacetoxytaxol og derivater deraf
ITMI913466A0 (it) Procedimento per la depurazione dell'1.1.1-trifluoro-2-fluoroetano e dell'1.1.1-trifuoro-2,2-diocloroetano
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
ATE148991T1 (de) Nicotinamid-adenin-dinukleodid enthaltendes antidepressionsmittel
DK435089D0 (da) Anvendelse af zofenopril til behandling af rheumatoid arthritis